Literature DB >> 136043

Chronic mesenteric arterial insufficiency: results of revascularization in 33 cases.

C H McCollum, J M Graham, M E DeBakey.   

Abstract

The symptoms of mesenteric arterial insufficiency and the advantages of surgical revascularization have become widely recognized in recent years. Follow-up data are accumulating on patients who have had surgery for revascularization. In this study we report on 33 patients who had mesenteric revascularization for intestinal angina. Twenty-nine patients presented with postprandial pain; most had weight loss. Abdominal bruits were heard preoperatively in 26 patients. Aortogram demonstrated involvement of one mesenteric vessel in 13 (39%) patients and two or more vessels in 20 (61%). Revascularization was accomplished with the use of a Dacron graft or an autogenous vein bypass graft to 48 vessels. Endarterectomy and patch angioplasty were done once. One patient died in the early postoperative period. Of the other 32 patients, 30 (94%) had relief of symptoms. Eight patients died from 8 to 135 months after operation, but only one died from mesenteric vascular occlusion and bowel infarction. Five years after operation, 83% of the patients were alive; in ten years, 62%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 136043     DOI: 10.1097/00007611-197610000-00006

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Transluminal angioplasty in the treatment of mesenteric vein graft stenosis.

Authors:  A Howd; H Loose; J Chamberlain
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

2.  Chronic visceral ischemia. Three decades of progress.

Authors:  C G Cunningham; L M Reilly; J H Rapp; P A Schneider; R J Stoney
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

3.  Chronic Mesenteric Ischemia: Differential Vascularsurgical Therapy and Its Outcome in a Single-Center Observational Study.

Authors:  Mohamed Essa; Frank Meyer; Robert Damm; Zuhir Halloul
Journal:  Visc Med       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.